Bihar CHO - 2021
Obstetrics & Gynaecology
Easy

What is the D.O.C (Drug of Choice) for Eclampsia?

Appeared in: Bihar CHO - 2021

Explanation

  • Magnesium Sulfate (MgSO₄) is the first-line drug for treating and preventing seizures in eclampsia.
  • It acts as a central nervous system depressant, cerebral vasodilator, and membrane stabilizer.
  • Large-scale clinical trials, such as the Magpie Trial, have confirmed its superiority over placebo and other anticonvulsants like phenytoin and diazepam in reducing the risk of eclampsia and maternal mortality.
  • Its primary role is seizure control, which is the most immediate life-threatening aspect of eclampsia for both mother and fetus.

Why Other Options Were Wrong

  • Option B: Phenytoin is an anticonvulsant, but it is significantly less effective than MgSO₄ for managing eclamptic seizures and is considered a second-line therapy.
  • Option C: Labetalol is an antihypertensive agent (a beta-blocker) used to control severe high blood pressure in eclampsia, not to treat or prevent seizures.
  • Option D: Hydralazine is an antihypertensive agent (a direct vasodilator) used to control severe high blood pressure. It does not have anticonvulsant properties.

Related Visual

Visual explanation — Related Visual
Clinical Relevance
  • Nursing practice connection: Knowing Pharmacological management of eclampsia helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
  • The nurse's role in administering MgSO₄ is critical and includes vigilant monitoring for signs of toxicity, which can be life-threatening. Key assessments include respiratory rate, deep tendon reflexes, and urine output.
  • Having the antidote, calcium gluconate, immediately available at the bedside is a crucial patient safety measure during MgSO₄ infusion.
  • Nurses must be able to differentiate between the management of seizures (with MgSO₄) and the management of hypertension (with labetalol/hydralazine), as both are critical components of eclampsia care.
How to Approach the Question
  • First, identify the core clinical problem in the question: 'Eclampsia'. This is an obstetric emergency defined by the onset of seizures in a woman with preeclampsia.
  • Next, determine the primary, life-threatening component of eclampsia that requires immediate treatment. This is the seizure activity.
  • Analyze the options provided and classify each drug by its primary function. MgSO₄ and Phenytoin are anticonvulsants. Labetalol and Hydralazine are antihypertensives.
  • Since the question asks for the drug of choice for eclampsia (seizures), eliminate the antihypertensives (Labetalol, Hydralazine) as they treat blood pressure, not the seizures themselves.
  • Between the two anticonvulsants, recall or deduce the first-line, most effective agent. Clinical guidelines and evidence overwhelmingly support Magnesium Sulfate as superior to Phenytoin for this specific indication.
  • Select MgSO₄ as the correct answer based on its established efficacy and role as the standard of care.
Concept Tested & Keywords
  • Concept Tested: Pharmacological management of eclampsia
  • Stem keywords: D.O.C, Drug of Choice, Eclampsia
  • Lead-in keywords: What is
  • Negative lead-in flag: false

Question ID

Q7gzFhQW3O6mLeWce-nTp

Reference Book

E6 Obstetrics Williams p. 33-53

Practise the full Bihar CHO - 2021

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Hypertensive Disorders in Pregnancy Questions

More Bihar CHO - 2021 Questions